SEC Form 4 · accession 0001179110-16-032658
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clive Meanwell
Officer — CEO · Director
Period of report
Dec 7, 2016
Accepted (ET)
Dec 9, 2016 · 12:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2016 | M | 40,000 | $28.60 | A | 379,168 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F2,F1 | $28.60 | Dec 7, 2016 | M | 40,000 | D | — | Feb 16, 2017 | Common Stock | 40,000 | 0 | D |
Explanation of responses
- F1This option vested in forty-eight equal installments beginning on March 16, 2007.
- F2Not applicable.